Telegram Restored on Apple App Store After Temporary Removal 
Palantir Stock Soars as AI Demand Drives Strong Q2 Earnings and Higher 2026 Outlook 
Holcim Raises 2026 Outlook After Strong Q2 Earnings Beat 
Amazon Q2 Earnings Beat Estimates as AWS AI Growth Surges, But Q3 Revenue Forecast Disappoints 
Prysmian Nears Deal to Acquire Atkore in Potential All-Cash Takeover 
SpaceX Earnings Preview: Bernstein Says 4 Key Factors Will Drive Long-Term Valuation 
Roblox Stock Drops 16% as Q3 Bookings Forecast Misses Expectations 
Apple Stock Slides 7% as Weak Sales Forecast Overshadows Quarterly Earnings Beat 
Nike China Strategy to Lift Margins Despite $1 Billion Sales Hit, Bernstein Says 
Japan Earthquake Disrupts Auto and Chip Supply Chains 
BYD July Global Vehicle Sales Rise 22% as Overseas Demand Surges 
Apple Q3 Earnings Beat as Record iPhone Sales Offset Services, China Weakness 
Alibaba Stock Jumps as Qwen 3.8-MAX AI Model Intensifies China's AI Race 
Chery Invests $75 Million in KG Mobility to Expand Global Automotive Partnership 
T-Mobile Executives Reportedly Oppose $300 Billion Deutsche Telekom Merger 
Same sparkle, different story: how lab-grown diamonds are transforming the market 
Anthropic Reveals Claude AI Accessed Real Production Systems During Cybersecurity Tests 
SAN FRANCISCO, April 10, 2018 -- Vascular access technology innovator Velano Vascular today announced that company leadership will present at a number of premier healthcare conferences in the second quarter.
Chief Executive Officer Eric M. Stone will moderate a discussion entitled “Innovation and the Four Pillars of Healthcare Progress” at Becker’s Hospital Review 9th Annual Meeting on Thursday, April 12th. Panelists include Patrick Charmel, President and CEO of Griffin Hospital; Kim Henrichsen, RN, MSN, SVP Clinical Operations and Chief Nursing Executive at Intermountain Healthcare; Chris Waugh, Chief Innovation Officer at Sutter Health; and Joan Zoltanski, MD, Chief Experience Officer, University Hospitals Health System.
Stone will also participate in the panel discussion “Strategic Investors Make or Break Us” at HLTH: The Future of Healthcare on Sunday, May 6th in Las Vegas, NV. This conversation will explore the role that strategic investors play in the new healthcare innovation model.
Chief Medical Officer Pitou Devgon, MD will join a panel discussion at The Patient Experience Symposium on Tuesday, May 8th entitled “Engaging Practitioners in Patient Experience Innovation”. Devgon will be joined by Cheryl H. O’Malley DNP, NEA-BC, Vice President, Patient Care Services and Nursing at University Hospitals Cleveland Medical Center.
About Velano Vascular
Velano Vascular is a medical device innovator committed to reducing the pain, risk and inefficiencies of traditional blood collection practices while enhancing the clinical domain of vascular access. The company’s revolutionary FDA-approved PIVO device expands the use of peripheral IV lines for frequent, high quality and needle free blood draws, aiming to deliver painless, compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. More information is available at www.velanovascular.com.
Press Contact:
Michael Azzano
Cosmo PR
[email protected]
415-596-1978
